PROVIDER PROFILE · NPI 1194867549

Bryan Urquhart

PRACTICEDIABETES AND THYROID ASSOCIATES PCSee all providers at this practice →

Physician AssistantFredericksburg, VAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

2,090

Beneficiaries

—

Total drug cost

$1.1M

Distinct drugs

Brand share

60.0%

Top prescribed drugs

Levothyroxine Sodium246 claims

Semaglutide204 claims

Glimepiride173 claims

Metformin Hcl154 claims

Metformin Hcl100 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$43K

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$15K

Compensation for serving as faculty or as a speaker for a medical education program$11K

Consulting Fee$10K

Travel and Lodging$5K

Food and Beverage$2K

REFERRAL NETWORK

Where Bryan Urquhart's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Mark Mcclanahan Endocrinology · Fredericksburg, VA	52	99

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Mark Mcclanahan Endocrinology · Fredericksburg, VA	31	56
MARY WASHINGTON HOSPITAL INC.	28	66
Laboratory Corporation Of America Holdings Clinical Laboratory · Burlington, NC	15	25
SPOTSYLVANIA MEDICAL CENTER INC	12	14

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history